SCM
NERV icon

Sterling Capital Management’s Minerva Neurosciences NERV Stock Holding History

Sterling Capital Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-6,517
Closed -$396K – 927
2017
Q3 		$396K Buy
6,517
+1,310
+25% +$75.1K ﹤0.01% 797
2017
Q2 		$369K Buy
5,207
+3,311
+175% +$214K ﹤0.01% 807
2017
Q1 		$123K Hold
1,896
– – ﹤0.01% 935
2016
Q4 		$178K Sell
1,896
-959
-34% -$97.9K ﹤0.01% 918
2016
Q3 		$322K Buy
2,855
+1,153
+68% +$112K ﹤0.01% 797
2016
Q2 		$139K Buy
1,702
+452
+36% +$28.7K ﹤0.01% 894
2016
Q1 		$61K Hold
1,250
– – ﹤0.01% 896
2015
Q4 		$61K Buy
+1,250
New +$52.2K ﹤0.01% 971

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
IVAV
Index Venture Associates V St. Helier, Channel Islands, Jersey $1.46M AUM 88.05% 1-Year Est. Return
AC
Ascend Capital Orinda, California $1.99B AUM 10.36% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Sterling Capital Management's NERV Position: Q4 2017 in Review

Sterling Capital Management sold out of Minerva Neurosciences (NERV) in Q4 2017, closing a stake of 6,517 shares — an estimated $396K sold.

Sterling Capital Management first reported a position in NERV in Q4 2015 and held it in 8 quarters. The position peaked at $396K in Q3 2017. 67 funds tracked by Wall St. Rank hold NERV as of Q4 2017.

  • Sterling Capital Management reported no remaining Minerva Neurosciences position as of Q4 2017 after selling out during the quarter.
  • Sterling Capital Management sold 6,517 Minerva Neurosciences shares in Q4 2017, an estimated $396K.
  • Sterling Capital Management first reported a position in Minerva Neurosciences in Q4 2015 and held it in 8 quarters.
  • Sterling Capital Management's Minerva Neurosciences position peaked at $396K in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2017.

Based on Sterling Capital Management's 13F filing for Q4 2017, filed 15 Feb 2018.